Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions. Poorbaugh J, Sims JT, Zhang L, Chang CY, et al. PLoS One 2025;20:e0324242.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Poorbaugh J, Sims JT, Zhang L, Chang CY, et al. Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions. PLoS One 2025;20:e0324242.
PMID: 40424310